A New Diagnostic Target in Insulinoma - Takeaway - MDSpire
Clinical Guidelines

A New Diagnostic Target in Insulinoma

DOCK10 expression tracks with insulin hypersecretion in tumor tissue

  • April 13, 2026

  • 3 min

Share

  • 1

    DOCK10 is a potential diagnostic marker for insulinoma.

  • 2

    Insulinomas cause significant hypoglycemia and are challenging to diagnose.

  • 3

    DOCK10 overexpression is specific to insulin-secreting tumors.

  • 4

    It may distinguish between functional and nonfunctional tumors.

  • 5

    Reduced DOCK10 expression decreases insulin secretion in models.

  • 6

    Research utilized organoids for future therapeutic models.

  • 7

    Cdc42 signaling pathway is linked to DOCK10 activity.

  • 8

    Study highlights tumor heterogeneity in insulinomas.

Original Source(s)

A New Diagnostic Target in Insulinoma

  • April 13, 2026

Related Content

Electroacupuncture May Relieve Cognitive, Psychological Symptoms in Breast Cancer Survivors in Pilot Study

Electroacupuncture may alleviate some persistent neuropsychiatric symptoms experienced by breast cancer survivors, including psychological distress and cognitive impairment, according to the results o...

Elinzanetant May Reduce Side Effects of Endocrine Therapy Among Patients With Breast Cancer

“Elinzanetant is the first approved targeted agent for [the vasomotor symptoms] that deeply affect the quality of life of breast cancer patients. By helping patients to tolerate better their breast ca...

Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds

Combining a visual inspection of the bladder—systematic endoscopic evaluation—with a blood test to check for the presence of ctDNA may accurately predict which patients with bladder cancer still have ...